Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of yoga in daily life program in rheumatoid arthritis: a randomized controlled trial [with consumer summary]
Puksic S, Mitrovic J, Culo M-I, Zivkovic M, Orehovec B, Bobek D, Morovic-Vergles J
Complementary Therapies in Medicine 2021 Mar;57:102639
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVES: To explore the feasibility and effectiveness of a yoga program in improving health-related quality of life (HQOL), physical and psychological functioning in rheumatoid arthritis (RA) patients. DESIGN: Single-centre parallel-arms randomized controlled trial comparing yoga (n = 30) and education control group (n = 27). SETTING: Tertiary care University hospital. INTERVENTION: A 12-week yoga program, based on the yoga in daily life system, included 2x weekly/90-minute sessions. The control group had 1xweekly/60-minute educational lectures on arthritis-related topics. MAIN OUTCOME MEASURES: Assessments were performed at baseline, 12 (post-intervention) and 24 weeks (follow-up). The primary outcome was change in The Short Form-36 (SF-36) HQOL at 12 weeks. Linear regression analysis was adjusted for baseline scores. RESULTS: No significant between-group differences were found for SF-36 (all p > 0.05). At 12 weeks the adjusted mean difference between groups favoured yoga for Functional Assessment of Chronic Illness Therapy-fatigue (5.08, CI 1.29 to 8.86; p = 0.009) and Hospital Anxiety and Depression Scale (HADS)-depression (-1.37, CI -2.38 to -0.36); p = 0.008) and at 24 weeks for HADS-anxiety (-1.79, CI -3.34 to -0.23; p = 0.025), while the impact on fatigue was sustained (5.43, CI 1.33 to 9.54, p = 0.01). The program had no impact on RA disease activity. Feasibility outcomes included recruitment rate 16%, retention 80.7%, and adherence to yoga 87.5 versus 82.7% for control. No serious adverse events were recorded. CONCLUSIONS: Yoga in daily life program was not associated with change in health-related quality of life of RA patients. Significant improvements in fatigue and mood were observed at postintervention and follow-up. This yoga program was found feasible and safe for patients and may complement standard RA treat-to-target strategy.

Full text (sometimes free) may be available at these link(s):      help